These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9445138)

  • 1. Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components.
    Kounelis S; Jones MW; Papadaki H; Bakker A; Swalsky P; Finkelstein SD
    Hum Pathol; 1998 Jan; 29(1):82-7. PubMed ID: 9445138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis.
    Jin Z; Ogata S; Tamura G; Katayama Y; Fukase M; Yajima M; Motoyama T
    Int J Gynecol Pathol; 2003 Oct; 22(4):368-73. PubMed ID: 14501818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.
    Chen X; Arend R; Hamele-Bena D; Tergas AI; Hawver M; Tong GX; Wright TC; Wright JD
    Int J Gynecol Pathol; 2017 Sep; 36(5):412-419. PubMed ID: 28700424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 protein overexpression and gene mutation in mixed Müllerian tumors of the uterus.
    Soong R; Knowles S; Hammond IG; Michael C; Iacopetta BJ
    Cancer Detect Prev; 1999; 23(1):8-12. PubMed ID: 9892985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis.
    Holst VA; Finkelstein S; Colby TV; Myers JL; Yousem SA
    Am J Surg Pathol; 1997 Jul; 21(7):801-11. PubMed ID: 9236836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
    Costa MJ; Guinee D
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation indices and p53-immunocytochemistry in uterine mixed mullerian tumors.
    Nicòtina PA; Ferlazzo G; Vincelli AM
    Histol Histopathol; 1997 Oct; 12(4):967-72. PubMed ID: 9302556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 immunostaining suggests that uterine carcinosarcomas are monoclonal.
    Mayall F; Rutty K; Campbell F; Goddard H
    Histopathology; 1994 Mar; 24(3):211-4. PubMed ID: 8200622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors.
    Buza N; Tavassoli FA
    Int J Gynecol Pathol; 2009 Nov; 28(6):514-21. PubMed ID: 19851197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed müllerian tumours.
    Abeln EC; Smit VT; Wessels JW; de Leeuw WJ; Cornelisse CJ; Fleuren GJ
    J Pathol; 1997 Dec; 183(4):424-31. PubMed ID: 9496259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant mixed müllerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis.
    Guarino M; Giordano F; Pallotti F; Polizzotti G; Tricomi P; Cristofori E
    Tumori; 1998; 84(3):391-7. PubMed ID: 9678624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of p53 pathway alterations in uterine carcinosarcomas (malignant mixed Müllerian tumors).
    Semczuk A; Ignatov A; Obrzut B; Reventos J; Rechberger T
    Oncology; 2014; 87(4):193-204. PubMed ID: 25033979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.
    Kernochan LE; Garcia RL
    J Natl Compr Canc Netw; 2009 May; 7(5):550-6; quiz 557. PubMed ID: 19460280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
    Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
    Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 is not related to Ki-67 immunostaining in the epithelial and mesenchymal components of female genital tract carcinosarcomas.
    Bałon B; Kaznowska E; Ignatov A; Steć A; Semczuk-Sikora A; Schneider-Stock R; Jóźwik M; Sulkowski S; Cybulski M; Szumiło J; Semczuk A
    Oncol Rep; 2013 Oct; 30(4):1661-8. PubMed ID: 23846734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 Expression in Carcinosarcomas of the Gynecologic Tract: A Potentially Actionable Biomarker.
    Pinto A; Mackrides N; Nadji M
    Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):393-397. PubMed ID: 27801734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in female genital tract carcinosarcomas (malignant mixed müllerian tumors). Clinicopathologic study of 82 cases.
    Costa MJ; Walls J
    Cancer; 1996 Feb; 77(3):533-42. PubMed ID: 8630962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant mullerian mixed tumor arising from ovarian serous carcinoma: a clinicopathologic and molecular study of two cases.
    Gallardo A; Matias-Guiu X; Lagarda H; Catasus L; Bussaglia E; Gras E; Suarez D; Prat J
    Int J Gynecol Pathol; 2002 Jul; 21(3):268-72. PubMed ID: 12068173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 gene mutation in female genital tract carcinosarcomas (malignant mixed müllerian tumors): a clinicopathologic study of 74 cases.
    Costa MJ; Vogelsan J; Young LJ
    Mod Pathol; 1994 Aug; 7(6):619-27. PubMed ID: 7991520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of mixed Müllerian tumours.
    D'Angelo E; Prat J
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):705-18. PubMed ID: 21742560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.